The EMA has approved the expansion of Greenwich LifeSciences’ Phase III FLAMINGO-01 breast cancer trial in Europe to add 11 new sites.

MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but ...

An Australian influencer who allegedly 'tortured' her 1-year-old daughter by making her sick amid a scam to get donations and ...

Natera has reported the latest data from the Phase III CALGB (Alliance)/SWOG 80702 study, indicating that Signatera, a ...

V.F. Corporation (NYSE:VFC) shares are trading higher in the premarket on Wednesday after the third-quarter FY25 earnings.

Lockheed Martin Corp (NYSE:LMT) shares are trading lower after the company reported mixed fourth-quarter 2024 results. The company reported a net sales decline of 1.3% year-over-year to $18.622 ...

Arena International’s Outsourcing in Clinical Trials West Coast 2025 will discuss patient centricity, diversity, and ...

Uganda has reported an outbreak of Ebola following the death of a nurse from the virus in the capital Kampala.

Tevogen Bio has expanded its partnership with Microsoft, aiming to further their collaboration centred on AI and advance ...

After hours: January 24 at 6:24:52 PM EST The average of price targets set by Wall Street analysts indicates a potential upside of 28.7% in Shutterstock (SSTK). While the effectiveness of this ...

Drowning out the usual squeak of trolley wheels and customers mumbling through their shopping list is Santana’s smooth ...